User profiles for GIAMPIERO GIROLOMONI

Giampiero Girolomoni

University of Verona
Verified email at univr.it
Cited by 42129

Prevalence of metabolic syndrome in patients with psoriasis: a hospital‐based case–control study

…, A Peserico, A Giannetti, G Girolomoni - British Journal of …, 2007 - academic.oup.com
Background Psoriasis is a chronic inflammatory disease associated with an increased
cardiovascular risk. Metabolic syndrome is a significant predictor of cardiovascular events. …

European S3-guidelines on the systemic treatment of psoriasis vulgaris

…, R Erdmann, J Ferguson, G Girolomoni… - Journal of the …, 2009 - art.torvergata.it
… D Pathirana, AD Ormerod, P Saiag, C Smith, PI Spuls, A Nast, J Barker, JD Bos, GR
Burmester, S Chimenti, L Dubertret, B Eberlein, R Erdmann, J Ferguson, G Girolomoni, P …

[HTML][HTML] Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions

…, M Ståhle, FO Nestle, G Girolomoni… - Journal of Investigative …, 2010 - Elsevier
Psoriasis is now classified as an immune-mediated inflammatory disease (IMID) of the skin.
It is being recognized that patients with various IMIDs, including psoriasis, are at higher risk …

Regulatory activity of autocrine IL-10 on dendritic cell functions

…, A la Sala, S Pastore, G Girolomoni - The Journal of …, 2001 - journals.aai.org
IL-10 is a critical cytokine that blocks the maturation of dendritic cells (DCs), but the relevance
of autocrine IL-10 on DC functions has not been investigated. In this study, we found that …

Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey

…, H Bachelez, J Barker, G Girolomoni… - Journal of the American …, 2014 - Elsevier
Background Available psoriasis surveys offer valuable information about psoriasis and psoriatic
arthritis (PsA), but are limited by methodology or enrollment requirements. Objective To …

IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist …

C Albanesi, A Cavani, G Girolomoni - The Journal of Immunology, 1999 - journals.aai.org
IL-17 is a novel T cell-derived cytokine that can regulate the functions of a variety of cell
types. In this study, we investigated whether hapten-specific T cells isolated from patients with …

[HTML][HTML] The epidermal growth factor receptor system in skin repair and inflammation

S Pastore, F Mascia, V Mariani, G Girolomoni - Journal of Investigative …, 2008 - Elsevier
The epidermal growth factor (EGF) family comprises multiple mediators such as transforming
growth factor-α, amphiregulin, heparin binding-EGF, and epiregulin, which are crucially …

Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate‐to‐severe plaque psoriasis over 52 weeks: a phase III, randomized …

…, K Shah, RM Day, G Girolomoni… - British Journal of …, 2015 - academic.oup.com
Background Apremilast, an oral phosphodiesterase 4 inhibitor, regulates immune responses
associated with psoriasis. Objectives ESTEEM 2 evaluated the efficacy and safety of …

Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment

…, M Parmentier, O De Pità, G Girolomoni… - Journal of Experimental …, 2009 - rupress.org
Psoriasis is a type I interferon-driven T cell–mediated disease characterized by the
recruitment of plasmacytoid dendritic cells (pDC) into the skin. The molecules involved in pDC …

European consensus statement on phenotypes of pustular psoriasis

…, K Ghoreschi, M Gilliet, G Girolomoni… - Journal of the …, 2017 - Wiley Online Library
Pustular psoriasis ( PP ) is a group of inflammatory skin conditions characterized by infiltration
of neutrophil granulocytes in the epidermis to such an extent that clinically visible sterile …